-
1
-
-
0026609559
-
Alternative excitotoxic hypotheses
-
1314341 1:STN:280:DyaK383ivVWmuw%3D%3D
-
Albin RL, Greenamyre JT (1992) Alternative excitotoxic hypotheses. Neurology 42:733-738
-
(1992)
Neurology
, vol.42
, pp. 733-738
-
-
Albin, R.L.1
Greenamyre, J.T.2
-
2
-
-
84872664970
-
Memantine reverses β-amyloid oligomers-induced deficits in long-term potentiation (LTP) in murine hippocampal slices
-
Nov 15-18, Washington, USA
-
Albrecht M, Rammes G, Gravius A, Parsons CG (2008) Memantine reverses β-amyloid oligomers-induced deficits in long-term potentiation (LTP) in murine hippocampal slices. Poster presented at 38th Society for Neuroscience Annual Meeting, Nov 15-18, Washington, USA
-
(2008)
38th Society for Neuroscience Annual Meeting
-
-
Albrecht, M.1
Rammes, G.2
Gravius, A.3
Parsons, C.G.4
-
3
-
-
32544439510
-
Simultaneous release of glutamate and acetylcholine from single magnocellular "cholinergic" basal forebrain neurons
-
16452682 1:CAS:528:DC%2BD28XhsFaitLc%3D
-
Allen TG, Abogadie FC, Brown DA (2006) Simultaneous release of glutamate and acetylcholine from single magnocellular "cholinergic" basal forebrain neurons. J Neurosci 26:1588-1595
-
(2006)
J Neurosci
, vol.26
, pp. 1588-1595
-
-
Allen, T.G.1
Abogadie, F.C.2
Brown, D.A.3
-
4
-
-
10744229632
-
Blockade of central cholinergic receptors impairs new learning and increases proactive interference in a word paired-associate memory task
-
14979800 1:CAS:528:DC%2BD2cXitVyqtbY%3D
-
Atri A, Sherman S, Norman KA, Kirchhoff BA, Nicolas MM, Greicius MD, Cramer SC, Breiter HC, Hasselmo ME, Stern CE (2004) Blockade of central cholinergic receptors impairs new learning and increases proactive interference in a word paired-associate memory task. Behav Neurosci 118:223-236
-
(2004)
Behav Neurosci
, vol.118
, pp. 223-236
-
-
Atri, A.1
Sherman, S.2
Norman, K.A.3
Kirchhoff, B.A.4
Nicolas, M.M.5
Greicius, M.D.6
Cramer, S.C.7
Breiter, H.C.8
Hasselmo, M.E.9
Stern, C.E.10
-
5
-
-
52649127458
-
Long-term course and effectiveness of combination therapy in Alzheimer disease
-
18580597 1:CAS:528:DC%2BD1cXhtVOiu7%2FE
-
Atri A, Shaughnessy LW, Locascio JJ, Growdon JH (2008) Long-term course and effectiveness of combination therapy in Alzheimer disease. Alzheimer Dis Assoc Disord 22:209-221
-
(2008)
Alzheimer Dis Assoc Disord
, vol.22
, pp. 209-221
-
-
Atri, A.1
Shaughnessy, L.W.2
Locascio, J.J.3
Growdon, J.H.4
-
6
-
-
84872399089
-
Memantine in patients with Alzheimer's disease receiving donepezil: New analyses of efficacy and safety for combination therapy
-
23336974 1:CAS:528:DC%2BC3sXjs12msbk%3D
-
Atri A, Molinuevo JL, Lemming O, Wirth Y, Pulte I, Wilkinson D (2013) Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy. Alzheimers Res Ther 5:6
-
(2013)
Alzheimers Res Ther
, vol.5
, pp. 6
-
-
Atri, A.1
Molinuevo, J.L.2
Lemming, O.3
Wirth, Y.4
Pulte, I.5
Wilkinson, D.6
-
7
-
-
0036810329
-
Alzheimer's disease and the basal forebrain cholinergic system: Relations to beta-amyloid peptides, cognition, and treatment strategies
-
12450488 1:CAS:528:DC%2BD38XovFeiurk%3D
-
Auld DS, Kornecook TJ, Bastianetto S, Quirion R (2002) Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 68:209-245
-
(2002)
Prog Neurobiol
, vol.68
, pp. 209-245
-
-
Auld, D.S.1
Kornecook, T.J.2
Bastianetto, S.3
Quirion, R.4
-
8
-
-
0034718202
-
Chronic treatment of old rats with donepezil or galantamine: Effects on memory, hippocampal plasticity and nicotinic receptors
-
10924948 1:CAS:528:DC%2BD3cXlt1Kis74%3D
-
Barnes CA, Meltzer J, Houston F, Orr G, McGann K, Wenk GL (2000) Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience 99:17-23
-
(2000)
Neuroscience
, vol.99
, pp. 17-23
-
-
Barnes, C.A.1
Meltzer, J.2
Houston, F.3
Orr, G.4
McGann, K.5
Wenk, G.L.6
-
9
-
-
77953625660
-
Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease
-
20540654 1:CAS:528:DC%2BC3cXnsVWgtbo%3D
-
Bassil N, Thaipisuttikul P, Grossberg GT (2010) Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease. Expert Opin Pharmacother 11:1765-1771
-
(2010)
Expert Opin Pharmacother
, vol.11
, pp. 1765-1771
-
-
Bassil, N.1
Thaipisuttikul, P.2
Grossberg, G.T.3
-
10
-
-
0020453289
-
Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: A combined fluorescent tracer and acetylcholinesterase analysis
-
6182962 1:CAS:528:DyaL38XlvFelsbY%3D
-
Bigl V, Woolf NJ, Butcher LL (1982) Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: a combined fluorescent tracer and acetylcholinesterase analysis. Brain Res Bull 8:727-749
-
(1982)
Brain Res Bull
, vol.8
, pp. 727-749
-
-
Bigl, V.1
Woolf, N.J.2
Butcher, L.L.3
-
11
-
-
44949179484
-
Cholinesterase inhibitors for Alzheimer's disease
-
doi: 10.1002/14651858
-
Birks J (2009) Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 1:CD005593. doi: 10.1002/14651858
-
(2009)
Cochrane Database Syst Rev
, vol.1
-
-
Birks, J.1
-
12
-
-
0032950029
-
The glutamatergic system and neurodegeneration in dementia: Preventive strategies in Alzheimer's disease
-
10029935 1:STN:280:DyaK1M7lsVWqtQ%3D%3D
-
Cacabelos R, Takeda M, Winblad B (1999) The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease. Int J Geriatr Psychiatry 14:3-47
-
(1999)
Int J Geriatr Psychiatry
, vol.14
, pp. 3-47
-
-
Cacabelos, R.1
Takeda, M.2
Winblad, B.3
-
14
-
-
0025642962
-
Sources of presumptive glutamatergic/aspartatergic afferents to the magnocellular basal forebrain in the rat
-
1982006 1:STN:280:DyaK3M7osFKluw%3D%3D
-
Carnes KM, Fuller TA, Price JL (1990) Sources of presumptive glutamatergic/aspartatergic afferents to the magnocellular basal forebrain in the rat. J Comp Neurol 302:824-852
-
(1990)
J Comp Neurol
, vol.302
, pp. 824-852
-
-
Carnes, K.M.1
Fuller, T.A.2
Price, J.L.3
-
15
-
-
0026564448
-
Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: Therapeutic advantage against NMDA receptor-mediated neurotoxicity
-
1432103 1:CAS:528:DyaK3sXntlY%3D
-
Chen H-SV, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA (1992) Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 12:4427-4436
-
(1992)
J Neurosci
, vol.12
, pp. 4427-4436
-
-
Chen, H.-S.1
Pellegrini, J.W.2
Aggarwal, S.K.3
Lei, S.Z.4
Warach, S.5
Jensen, F.E.6
Lipton, S.A.7
-
16
-
-
33746825134
-
Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment
-
Memantine MEM-MD-02 Study Group 16832078 1:CAS:528:DC%2BD28XlvFylu7o%3D
-
Cummings JL, Schneider E, Tariot PN, Graham SM, Memantine MEM-MD-02 Study Group (2006) Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. Neurology 67:57-63
-
(2006)
Neurology
, vol.67
, pp. 57-63
-
-
Cummings, J.L.1
Schneider, E.2
Tariot, P.N.3
Graham, S.M.4
-
17
-
-
33644835280
-
Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment
-
16409439 1:CAS:528:DC%2BD28XitFSltbs%3D
-
Dantoine T, Auriacombe S, Sarazin M, Becker H, Pere JJ, Bourdeix I (2006) Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment. Int J Clin Pract 60:110-118
-
(2006)
Int J Clin Pract
, vol.60
, pp. 110-118
-
-
Dantoine, T.1
Auriacombe, S.2
Sarazin, M.3
Becker, H.4
Pere, J.J.5
Bourdeix, I.6
-
18
-
-
0141707078
-
The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: Preclinical evidence
-
12973747
-
Danysz W, Parsons CG (2003) The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Int J Geriatr Psychiatry 18:S23-S32
-
(2003)
Int J Geriatr Psychiatry
, vol.18
-
-
Danysz, W.1
Parsons, C.G.2
-
19
-
-
0001788650
-
Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease - A unified glutamatergic hypothesis on the mechanism of action
-
16787834 1:CAS:528:DC%2BD3cXot1Cqsrg%3D
-
Danysz W, Parsons CG, Mobius HJ, Stoffler A, Quack G (2000) Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease - a unified glutamatergic hypothesis on the mechanism of action. Neurotox Res 2:85-97
-
(2000)
Neurotox Res
, vol.2
, pp. 85-97
-
-
Danysz, W.1
Parsons, C.G.2
Mobius, H.J.3
Stoffler, A.4
Quack, G.5
-
20
-
-
0035896466
-
Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease
-
11226635 1:CAS:528:DC%2BD3MXhsFSiurc%3D
-
Davidsson P, Blennow K, Andreasen N, Eriksson B, Minthon L, Hesse C (2001) Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease. Neurosci Lett 300:157-160
-
(2001)
Neurosci Lett
, vol.300
, pp. 157-160
-
-
Davidsson, P.1
Blennow, K.2
Andreasen, N.3
Eriksson, B.4
Minthon, L.5
Hesse, C.6
-
21
-
-
34249672242
-
Abeta oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine
-
17308309
-
De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL (2007) Abeta oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282:11590-11601
-
(2007)
J Biol Chem
, vol.282
, pp. 11590-11601
-
-
De Felice, F.G.1
Velasco, P.T.2
Lambert, M.P.3
Viola, K.4
Fernandez, S.J.5
Ferreira, S.T.6
Klein, W.L.7
-
22
-
-
1842453883
-
Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones
-
14744806
-
Di Angelantonio S, Bernardi G, Mercuri NB (2004) Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones. Br J Pharmacol 141:644-652
-
(2004)
Br J Pharmacol
, vol.141
, pp. 644-652
-
-
Di Angelantonio, S.1
Bernardi, G.2
Mercuri, N.B.3
-
23
-
-
0028826399
-
Cholinomimetics increase glutamate outflow via an action on the corticostriatal pathway: Implications for Alzheimer's disease
-
7595503 1:CAS:528:DyaK2MXovFGmtb4%3D
-
Dijk SN, Francis PT, Stratmann GC, Bowen DM (1995) Cholinomimetics increase glutamate outflow via an action on the corticostriatal pathway: implications for Alzheimer's disease. J Neurochem 65:2165-2169
-
(1995)
J Neurochem
, vol.65
, pp. 2165-2169
-
-
Dijk, S.N.1
Francis, P.T.2
Stratmann, G.C.3
Bowen, D.M.4
-
25
-
-
0017652462
-
Memory and cognitive function in man: Does the cholinergic system have a specific role?
-
560649 1:STN:280:DyaE2s3jtlSisw%3D%3D
-
Drachman DA (1977) Memory and cognitive function in man: does the cholinergic system have a specific role? Neurology 27:783-790
-
(1977)
Neurology
, vol.27
, pp. 783-790
-
-
Drachman, D.A.1
-
26
-
-
79955744677
-
The cholinergic system and hippocampal plasticity
-
21130117 1:CAS:528:DC%2BC3MXmtFClu7o%3D
-
Drever BD, Riedel G, Platt B (2011) The cholinergic system and hippocampal plasticity. Behav Brain Res 221:505-514
-
(2011)
Behav Brain Res
, vol.221
, pp. 505-514
-
-
Drever, B.D.1
Riedel, G.2
Platt, B.3
-
27
-
-
3242690679
-
Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain
-
15275830 1:CAS:528:DC%2BD2cXmtVCjtbk%3D
-
Enz A, Gentsch C (2004) Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain. Neuropharmacology 47:408-413
-
(2004)
Neuropharmacology
, vol.47
, pp. 408-413
-
-
Enz, A.1
Gentsch, C.2
-
28
-
-
0035283713
-
Basal forebrain glutamatergic modulation of cortical acetylcholine release
-
11169769 1:CAS:528:DC%2BD3MXns1GhsQ%3D%3D
-
Fadel J, Sarter M, Bruno JP (2001) Basal forebrain glutamatergic modulation of cortical acetylcholine release. Synapse 39:201-212
-
(2001)
Synapse
, vol.39
, pp. 201-212
-
-
Fadel, J.1
Sarter, M.2
Bruno, J.P.3
-
29
-
-
0035964226
-
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
-
Donepezil MSAD Study Investigators Group 11524468 1:CAS:528: DC%2BD3MXmslymtrg%3D
-
Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E, Donepezil MSAD Study Investigators Group (2001) A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology 57:613-620
-
(2001)
Neurology
, vol.57
, pp. 613-620
-
-
Feldman, H.1
Gauthier, S.2
Hecker, J.3
Vellas, B.4
Subbiah, P.5
Whalen, E.6
-
30
-
-
33845439410
-
Activities of daily living in moderate-to-severe Alzheimer disease: An analysis of the treatment effects of memantine in patients receiving stable donepezil treatment
-
Memantine MEM-MD-02 Study Group 17132971 1:CAS:528:DC%2BD28Xht1Cnt77N
-
Feldman HH, Schmitt FA, Olin JT, Memantine MEM-MD-02 Study Group (2006) Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment. Alzheimer Dis Assoc Disord 20:263-268
-
(2006)
Alzheimer Dis Assoc Disord
, vol.20
, pp. 263-268
-
-
Feldman, H.H.1
Schmitt, F.A.2
Olin, J.T.3
-
31
-
-
0346729783
-
Cortical acetylcholine release and electroencephalogram activation evoked by ionotropic glutamate receptor agonists in the rat basal forebrain
-
14706791 1:CAS:528:DC%2BD2cXosFWr
-
Fournier GN, Materi LM, Semba K, Rasmusson DD (2004) Cortical acetylcholine release and electroencephalogram activation evoked by ionotropic glutamate receptor agonists in the rat basal forebrain. Neuroscience 123:785-792
-
(2004)
Neuroscience
, vol.123
, pp. 785-792
-
-
Fournier, G.N.1
Materi, L.M.2
Semba, K.3
Rasmusson, D.D.4
-
32
-
-
0021797563
-
Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment
-
2582256 1:CAS:528:DyaL2MXmtFaltbo%3D
-
Francis PT, Palmer AM, Sims NR, Bowen DM, Davison AN, Esiri MM, Neary D, Snowden JS, Wilcock GK (1985) Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. N Engl J Med 313:7-11
-
(1985)
N Engl J Med
, vol.313
, pp. 7-11
-
-
Francis, P.T.1
Palmer, A.M.2
Sims, N.R.3
Bowen, D.M.4
Davison, A.N.5
Esiri, M.M.6
Neary, D.7
Snowden, J.S.8
Wilcock, G.K.9
-
33
-
-
0027269660
-
Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: Investigative and therapeutic perspectives
-
8473885 1:CAS:528:DyaK3sXktVKjsrY%3D
-
Francis PT, Sims NR, Procter AW, Bowen DM (1993) Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives. J Neurochem 60:1589-1604
-
(1993)
J Neurochem
, vol.60
, pp. 1589-1604
-
-
Francis, P.T.1
Sims, N.R.2
Procter, A.W.3
Bowen, D.M.4
-
35
-
-
19144372322
-
Effects of memantine on behavioural symptoms in Alzheimer's disease patients: An analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies
-
15852444 1:STN:280:DC%2BD2M3ivVKrug%3D%3D
-
Gauthier S, Wirth Y, Möbius HJ (2005) Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies. Int J Geriatr Psychiatry 20:459-464
-
(2005)
Int J Geriatr Psychiatry
, vol.20
, pp. 459-464
-
-
Gauthier, S.1
Wirth, Y.2
Möbius, H.J.3
-
36
-
-
0141818332
-
Cholinergic function and Alzheimer's disease
-
12973744
-
Giacobini E (2003) Cholinergic function and Alzheimer's disease. Int J Geriatr Psychiatry 18:S1-S5
-
(2003)
Int J Geriatr Psychiatry
, vol.18
-
-
Giacobini, E.1
-
37
-
-
0024810785
-
The cholinergic receptor system of the human brain: Neurochemical and pharmacological aspects in aging and Alzheimer
-
2685904 1:CAS:528:DyaK3cXktVertrw%3D
-
Giacobini E, DeSarno P, Clark B, McIlhany M (1989) The cholinergic receptor system of the human brain: neurochemical and pharmacological aspects in aging and Alzheimer. Prog Brain Res 79:335-343
-
(1989)
Prog Brain Res
, vol.79
, pp. 335-343
-
-
Giacobini, E.1
Desarno, P.2
Clark, B.3
McIlhany, M.4
-
38
-
-
80755156409
-
Long-term progression of Alzheimer's disease in patients under antidementia drugs
-
22055975
-
Gillette-Guyonnet S, Andrieu s, Nourhashemi F, Gardette V, Coley N, Cantet C, Gauthier S, Ousset PJ, Vellas B (2011) Long-term progression of Alzheimer's disease in patients under antidementia drugs. Alzheimers Dement 7:579-592
-
(2011)
Alzheimers Dement
, vol.7
, pp. 579-592
-
-
Gillette-Guyonnet, S.1
Andrieu, S.2
Nourhashemi, F.3
Gardette, V.4
Coley, N.5
Cantet, C.6
Gauthier, S.7
Ousset, P.J.8
Vellas, B.9
-
39
-
-
0028218273
-
NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus - A microdialysis study
-
8120631 1:CAS:528:DyaK2cXitV2hsbg%3D
-
Giovannini MG, Mutolo D, Bianchi L, Michelassi A, Pepeu G (1994) NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus - a microdialysis study. J Neurosci 14:1358-1365
-
(1994)
J Neurosci
, vol.14
, pp. 1358-1365
-
-
Giovannini, M.G.1
Mutolo, D.2
Bianchi, L.3
Michelassi, A.4
Pepeu, G.5
-
40
-
-
0024363934
-
Excitatory amino acids and Alzheimer's disease
-
2554168 1:CAS:528:DyaL1MXmtFalsLY%3D
-
Greenamyre JT, Young AB (1989) Excitatory amino acids and Alzheimer's disease. Neurobiol Aging 10:593-602
-
(1989)
Neurobiol Aging
, vol.10
, pp. 593-602
-
-
Greenamyre, J.T.1
Young, A.B.2
-
41
-
-
80051795817
-
A multinational, randomized, double-blind, placebo-controlled parallel-group trial of memantine extended-release capsule (28 mg, once daily) in patients with moderate to severe Alzheimer's disease
-
Grossberg GT, Manes F, Allegri R (2008) A multinational, randomized, double-blind, placebo-controlled parallel-group trial of memantine extended-release capsule (28 mg, once daily) in patients with moderate to severe Alzheimer's disease. Alzheimers Dement 4:T793
-
(2008)
Alzheimers Dement
, vol.4
, pp. 793
-
-
Grossberg, G.T.1
Manes, F.2
Allegri, R.3
-
42
-
-
18044388911
-
Memantine does not influence AChE inhibition in rat brain by donepezil or rivastigmine but does with DFP and metrifonate in in vivo studies
-
1:CAS:528:DC%2BD2MXktFSrurg%3D
-
Gupta RC, Dekundy A (2005) Memantine does not influence AChE inhibition in rat brain by donepezil or rivastigmine but does with DFP and metrifonate in in vivo studies. Drug Dev Res 64:71-81
-
(2005)
Drug Dev Res
, vol.64
, pp. 71-81
-
-
Gupta, R.C.1
Dekundy, A.2
-
44
-
-
0037345885
-
Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy
-
12598818
-
Hartmann S, Möbius HJ (2003) Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy. Int Clin Psychopharmacol 18:81-85
-
(2003)
Int Clin Psychopharmacol
, vol.18
, pp. 81-85
-
-
Hartmann, S.1
Möbius, H.J.2
-
45
-
-
77956629252
-
EFNS guidelines for the diagnosis and management of Alzheimer's disease
-
20831773 1:STN:280:DC%2BC3cfltl2qug%3D%3D
-
Hort J, O'Brien JT, Gainotti G, Pirttila T, Popescu BO, Rektorova I, Sorbi S, Scheltens P (2010) EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol 17:1236-1248
-
(2010)
Eur J Neurol
, vol.17
, pp. 1236-1248
-
-
Hort, J.1
O'Brien, J.T.2
Gainotti, G.3
Pirttila, T.4
Popescu, B.O.5
Rektorova, I.6
Sorbi, S.7
Scheltens, P.8
-
46
-
-
84863229484
-
Donepezil and memantine for moderate-to-severe Alzheimer's disease
-
22397651 1:CAS:528:DC%2BC38XktFOgtbs%3D
-
Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Hughes A (2012) Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med 366:893-903
-
(2012)
N Engl J Med
, vol.366
, pp. 893-903
-
-
Howard, R.1
McShane, R.2
Lindesay, J.3
Ritchie, C.4
Baldwin, A.5
Barber, R.6
Burns, A.7
Dening, T.8
Findlay, D.9
Holmes, C.10
Hughes, A.11
-
47
-
-
0027491609
-
Changes in G protein-mediated signal transduction in aging and Alzheimer's disease
-
8239310 1:CAS:528:DyaK2cXnsVegtA%3D%3D
-
Joseph JA, Cutler R, Roth GS (1993) Changes in G protein-mediated signal transduction in aging and Alzheimer's disease. Ann N Y Acad Sci 695:42-45
-
(1993)
Ann N y Acad Sci
, vol.695
, pp. 42-45
-
-
Joseph, J.A.1
Cutler, R.2
Roth, G.S.3
-
48
-
-
0026706896
-
Memantine prevents quinolinic acid-induced hippocampal damage
-
1425971 1:CAS:528:DyaK38XmtVGjtbY%3D
-
Keilhoff G, Wolf G (1992) Memantine prevents quinolinic acid-induced hippocampal damage. Eur J Pharmacol 219:451-454
-
(1992)
Eur J Pharmacol
, vol.219
, pp. 451-454
-
-
Keilhoff, G.1
Wolf, G.2
-
49
-
-
53749087290
-
Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine
-
18690555 1:CAS:528:DC%2BD1cXhtVSgtLrL
-
Kenney JW, Gould TJ (2008) Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol 38:101-121
-
(2008)
Mol Neurobiol
, vol.38
, pp. 101-121
-
-
Kenney, J.W.1
Gould, T.J.2
-
50
-
-
34248509900
-
Molecules that disrupt memory circuits in Alzheimer's disease: The attack on synapses by Aβ oligomers (ADDLs)
-
B. Bontempi A.J. Silva Y. Christen (eds) Springer Berlin
-
Klein WL, Lacor PN, De Felice FG, Ferreira ST (2007) Molecules that disrupt memory circuits in Alzheimer's disease: the attack on synapses by Aβ oligomers (ADDLs). In: Bontempi B, Silva AJ, Christen Y (eds) Memories: molecules and circuits. Springer, Berlin, pp 155-179
-
(2007)
Memories: Molecules and Circuits
, pp. 155-179
-
-
Klein, W.L.1
Lacor, P.N.2
De Felice, F.G.3
Ferreira, S.T.4
-
51
-
-
79953061290
-
Protection against Abeta-mediated rapid disruption of synaptic plasticity and memory by memantine
-
19446369 1:CAS:528:DC%2BC3MXktFKgu7w%3D
-
Klyubin I, Wang Q, Reed MN, Irving EA, Upton N, Hofmeister J, Cleary JP, Anwyl R, Rowan MJ (2011) Protection against Abeta-mediated rapid disruption of synaptic plasticity and memory by memantine. Neurobiol Aging 32:614-623
-
(2011)
Neurobiol Aging
, vol.32
, pp. 614-623
-
-
Klyubin, I.1
Wang, Q.2
Reed, M.N.3
Irving, E.A.4
Upton, N.5
Hofmeister, J.6
Cleary, J.P.7
Anwyl, R.8
Rowan, M.J.9
-
52
-
-
0031048111
-
Psychotogenicity and N-methyl-d-aspartate receptor antagonism: Implications for neuroprotective pharmacotherapy
-
9018383 1:CAS:528:DyaK2sXotlaqtA%3D%3D
-
Kornhuber J, Weller M (1997) Psychotogenicity and N-methyl-d-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy. Biol Psychiatry 41:135-144
-
(1997)
Biol Psychiatry
, vol.41
, pp. 135-144
-
-
Kornhuber, J.1
Weller, M.2
-
53
-
-
80054896238
-
Economic evaluation of the impact of memantine on time to nursing home admission in the treatment of Alzheimer disease
-
22014692
-
Lachaine J, Beauchemin C, Legault M, Bineau S (2011) Economic evaluation of the impact of memantine on time to nursing home admission in the treatment of Alzheimer disease. Can J Psychiatry 56:596-604
-
(2011)
Can J Psychiatry
, vol.56
, pp. 596-604
-
-
Lachaine, J.1
Beauchemin, C.2
Legault, M.3
Bineau, S.4
-
54
-
-
33846633336
-
Aβ oligomers-induced aberrations in synapse composition, shape and density provide a molecular basis for loss of connectivity in Alzheimer's disease
-
17251419 1:CAS:528:DC%2BD2sXhs1Wrsbc%3D
-
Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Aβ oligomers-induced aberrations in synapse composition, shape and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27:796-807
-
(2007)
J Neurosci
, vol.27
, pp. 796-807
-
-
Lacor, P.N.1
Buniel, M.C.2
Furlow, P.W.3
Clemente, A.S.4
Velasco, P.T.5
Wood, M.6
Viola, K.L.7
Klein, W.L.8
-
55
-
-
0031765270
-
Glutamate toxicity in chronic neurodegenerative disease
-
9932386 1:CAS:528:DyaK1cXotVCmurc%3D
-
Lancelot E, Beal MF (1998) Glutamate toxicity in chronic neurodegenerative disease. Prog Brain Res 116:331-347
-
(1998)
Prog Brain Res
, vol.116
, pp. 331-347
-
-
Lancelot, E.1
Beal, M.F.2
-
56
-
-
66149095869
-
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
-
19204022 1:STN:280:DC%2BD1Mzksl2ksg%3D%3D
-
Lopez OL, Becker JT, Wahed AS, Saxton J, Sweet RA, Wolk DA, Klunk W, Dekosky ST (2009) Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease. J Neurol Neurosurg Psychiatry 80:600-607
-
(2009)
J Neurol Neurosurg Psychiatry
, vol.80
, pp. 600-607
-
-
Lopez, O.L.1
Becker, J.T.2
Wahed, A.S.3
Saxton, J.4
Sweet, R.A.5
Wolk, D.A.6
Klunk, W.7
Dekosky, S.T.8
-
57
-
-
84876918518
-
Combination of memantine and donepezil reverses cognitive deficits in transgenic mice with both amyloid-beta plaques and neurofibrillary tangles
-
Sept 12-16, Istanbul, Turkey
-
Martinez-Coria H, Green K, Banerjee PK, LaFerla FM (2009) Combination of memantine and donepezil reverses cognitive deficits in transgenic mice with both amyloid-beta plaques and neurofibrillary tangles. Poster presented at 22nd Congress of the European College of Neuropsychopharmacology (ECNP), Sept 12-16, Istanbul, Turkey
-
(2009)
22nd Congress of the European College of Neuropsychopharmacology (ECNP)
-
-
Martinez-Coria, H.1
Green, K.2
Banerjee, P.K.3
Laferla, F.M.4
-
58
-
-
76149120867
-
Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice
-
20042680 1:CAS:528:DC%2BC3cXitFCmsbo%3D
-
Martinez-Coria H, Green KN, Billings LM, Kitazawa M, Albrecht M, Rammes G, Parsons CG, Gupta S, Banerjee P, LaFerla FM (2010) Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice. Am J Pathol 176:870-880
-
(2010)
Am J Pathol
, vol.176
, pp. 870-880
-
-
Martinez-Coria, H.1
Green, K.N.2
Billings, L.M.3
Kitazawa, M.4
Albrecht, M.5
Rammes, G.6
Parsons, C.G.7
Gupta, S.8
Banerjee, P.9
Laferla, F.M.10
-
60
-
-
0021319490
-
Neural inputs into the nucleus basalis of the substantia innominata (Ch4) in the rhesus monkey
-
6538106
-
Mesulam MM, Mufson EJ (1984) Neural inputs into the nucleus basalis of the substantia innominata (Ch4) in the rhesus monkey. Brain 107:253-274
-
(1984)
Brain
, vol.107
, pp. 253-274
-
-
Mesulam, M.M.1
Mufson, E.J.2
-
61
-
-
0018385416
-
The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory
-
450929 1:CAS:528:DyaE1MXktFeqtL8%3D
-
Mewaldt SP, Ghoneim MM (1979) The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory. Pharmacol Biochem Behav 10:205-210
-
(1979)
Pharmacol Biochem Behav
, vol.10
, pp. 205-210
-
-
Mewaldt, S.P.1
Ghoneim, M.M.2
-
62
-
-
0037146905
-
Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1-40)
-
12468047 1:CAS:528:DC%2BD38XptFelurg%3D
-
Miguel-Hidalgo JJ, Alvarex XA, Cacabelos R, Quack G (2002) Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1-40). Brain Res 958:210-221
-
(2002)
Brain Res
, vol.958
, pp. 210-221
-
-
Miguel-Hidalgo, J.J.1
Alvarex, X.A.2
Cacabelos, R.3
Quack, G.4
-
63
-
-
0030052030
-
Learning deficits induced by chronic intraventricular infusion of quinolinic acid - Protection by MK-801 and memantine
-
8720470 1:CAS:528:DyaK28XkslKqtw%3D%3D
-
Misztal M, Frankiewicz T, Parsons CG, Danysz W (1996) Learning deficits induced by chronic intraventricular infusion of quinolinic acid - protection by MK-801 and memantine. Eur J Pharmacol 296:1-8
-
(1996)
Eur J Pharmacol
, vol.296
, pp. 1-8
-
-
Misztal, M.1
Frankiewicz, T.2
Parsons, C.G.3
Danysz, W.4
-
64
-
-
0029931273
-
Septal and hippocampal glutamate receptors modulate the output of acetylcholine in hippocampus: A microdialysis study
-
8667007 1:CAS:528:DyaK28Xjs1yjt78%3D
-
Moor E, Auth F, DeBoer P, Westerink BHC (1996) Septal and hippocampal glutamate receptors modulate the output of acetylcholine in hippocampus: a microdialysis study. J Neurochem 67:310-316
-
(1996)
J Neurochem
, vol.67
, pp. 310-316
-
-
Moor, E.1
Auth, F.2
Deboer, P.3
Westerink, B.H.C.4
-
65
-
-
0036125305
-
Glutamate exacerbates amyloid beta1-42-induced impairment of long-term potentiation in rat hippocampal slices
-
11928725 1:CAS:528:DC%2BD38XhslyjsLc%3D
-
Nakagami Y, Oda T (2002) Glutamate exacerbates amyloid beta1-42-induced impairment of long-term potentiation in rat hippocampal slices. Jpn J Pharmacol 88:223-226
-
(2002)
Jpn J Pharmacol
, vol.88
, pp. 223-226
-
-
Nakagami, Y.1
Oda, T.2
-
66
-
-
84861523642
-
Synergistic effects of antidementia drugs on spatial learning and recall in the APP23 transgenic mouse model of Alzheimer's disease
-
22414570 1:CAS:528:DC%2BC38Xnt1Cis74%3D
-
Neumeister KL, Riepe MW (2012) Synergistic effects of antidementia drugs on spatial learning and recall in the APP23 transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 30:245-251
-
(2012)
J Alzheimers Dis
, vol.30
, pp. 245-251
-
-
Neumeister, K.L.1
Riepe, M.W.2
-
67
-
-
0033006151
-
Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide
-
10426500 1:CAS:528:DyaK1MXksVegsbw%3D
-
Noda M, Nakanishi H, Akaike N (1999) Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience 92:1465-1474
-
(1999)
Neuroscience
, vol.92
, pp. 1465-1474
-
-
Noda, M.1
Nakanishi, H.2
Akaike, N.3
-
68
-
-
0035251677
-
Nicotinic receptor abnormalities of Alzheimer's disease: Therapeutic implications
-
11230871 1:CAS:528:DC%2BD3MXhsFSjtbw%3D
-
Nordberg A (2001) Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol Psychiatry 49:200-210
-
(2001)
Biol Psychiatry
, vol.49
, pp. 200-210
-
-
Nordberg, A.1
-
69
-
-
79955746908
-
The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine
-
20553766 1:CAS:528:DC%2BC3MXmtFCksr0%3D
-
Nyakas C, Granic I, Halmy LG, Banerjee P, Luiten PG (2011) The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine. Behav Brain Res 221:594-603
-
(2011)
Behav Brain Res
, vol.221
, pp. 594-603
-
-
Nyakas, C.1
Granic, I.2
Halmy, L.G.3
Banerjee, P.4
Luiten, P.G.5
-
70
-
-
0025282045
-
Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?
-
2165009 1:CAS:528:DyaK3cXltFeju7k%3D
-
Palmer AM, Gershon S (1990) Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic? FASEB J 4:2745-2752
-
(1990)
FASEB J
, vol.4
, pp. 2745-2752
-
-
Palmer, A.M.1
Gershon, S.2
-
71
-
-
0027731677
-
Patch clamp studies on the kinetics and selectivity of N-methyl-d-aspartate receptor antagonism by memantine (1-amino-3,5- dimethyladamantan)
-
8152525 1:CAS:528:DyaK2cXpsFGrtA%3D%3D
-
Parsons CG, Gruner R, Rozental J, Millar J, Lodge D (1993) Patch clamp studies on the kinetics and selectivity of N-methyl-d-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology 32:1337-1350
-
(1993)
Neuropharmacology
, vol.32
, pp. 1337-1350
-
-
Parsons, C.G.1
Gruner, R.2
Rozental, J.3
Millar, J.4
Lodge, D.5
-
72
-
-
0032467053
-
Glutamate in CNS disorders as a target for drug development: An update
-
15616669 1:CAS:528:DyaK1MXhs12lsr8%3D
-
Parsons CG, Danysz W, Quack G (1998) Glutamate in CNS disorders as a target for drug development: an update. Drug News Perspect 11:523-569
-
(1998)
Drug News Perspect
, vol.11
, pp. 523-569
-
-
Parsons, C.G.1
Danysz, W.2
Quack, G.3
-
73
-
-
0032968779
-
Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: In vitro and in vivo characterization
-
10193901 1:CAS:528:DyaK1MXhsF2htr0%3D
-
Parsons CG, Danysz W, Bartmann A, Spielmanns P, Frankiewicz T, Hesselink M, Eilbacher B, Quack G (1999a) Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization. Neuropharmacology 38:85-108
-
(1999)
Neuropharmacology
, vol.38
, pp. 85-108
-
-
Parsons, C.G.1
Danysz, W.2
Bartmann, A.3
Spielmanns, P.4
Frankiewicz, T.5
Hesselink, M.6
Eilbacher, B.7
Quack, G.8
-
74
-
-
0032892343
-
Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist - A review of preclinical data
-
10465680 1:CAS:528:DyaK1MXjslGjsbY%3D
-
Parsons CG, Danysz W, Quack G (1999b) Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacology 38:735-767
-
(1999)
Neuropharmacology
, vol.38
, pp. 735-767
-
-
Parsons, C.G.1
Danysz, W.2
Quack, G.3
-
75
-
-
34948842904
-
Memantine: A NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - Too little activation is bad, too much is even worse
-
17904591 1:CAS:528:DC%2BD2sXhtFGrsLzF
-
Parsons CG, Stöffler A, Danysz W (2007) Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse. Neuropharmacology 53:699-723
-
(2007)
Neuropharmacology
, vol.53
, pp. 699-723
-
-
Parsons, C.G.1
Stöffler, A.2
Danysz, W.3
-
76
-
-
79959987552
-
Combination therapy for Alzheimer's disease
-
21721598 1:CAS:528:DC%2BC3MXhtFGgu7zO
-
Patel L, Grossberg GT (2011) Combination therapy for Alzheimer's disease. Drugs Aging 28:539-546
-
(2011)
Drugs Aging
, vol.28
, pp. 539-546
-
-
Patel, L.1
Grossberg, G.T.2
-
77
-
-
4143051189
-
Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil
-
15266045 1:CAS:528:DC%2BD2cXnslyisbg%3D
-
Periclou AP, Ventura D, Sherman T, Rao N, Abramowitz WT (2004) Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil. Ann Pharmacother 38:1389-1394
-
(2004)
Ann Pharmacother
, vol.38
, pp. 1389-1394
-
-
Periclou, A.P.1
Ventura, D.2
Sherman, T.3
Rao, N.4
Abramowitz, W.T.5
-
78
-
-
0018078940
-
Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
-
719462 1:STN:280:DyaE1M%2Fmtlarsw%3D%3D
-
Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2:1457-1459
-
(1978)
Br Med J
, vol.2
, pp. 1457-1459
-
-
Perry, E.K.1
Tomlinson, B.E.2
Blessed, G.3
Bergmann, K.4
Gibson, P.H.5
Perry, R.H.6
-
79
-
-
0033018477
-
Acetylcholine in mind: A neurotransmitter correlate of consciousness?
-
10354606 1:CAS:528:DyaK1MXjvVemtbY%3D
-
Perry E, Walker M, Grace J, Perry R (1999) Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci 22:273-280
-
(1999)
Trends Neurosci
, vol.22
, pp. 273-280
-
-
Perry, E.1
Walker, M.2
Grace, J.3
Perry, R.4
-
80
-
-
0017755565
-
Scopolamine induced learning failures in man
-
406632 1:CAS:528:DyaE2sXkslymtLo%3D
-
Petersen RC (1977) Scopolamine induced learning failures in man. Psychopharmacology 52:283-289
-
(1977)
Psychopharmacology
, vol.52
, pp. 283-289
-
-
Petersen, R.C.1
-
81
-
-
33845922830
-
The N-butylcarbamate derivative of galantamine acts as an allosteric potentiating ligand on alpha7 nicotinic receptors in hippocampal neurons: Clinical implications for treatment of Alzheimer's disease
-
17192682 1:CAS:528:DC%2BD28XhtlWgurnN
-
Popa RV, Pereira EF, Lopes C, Maelicke A, Albuquerque EX (2006) The N-butylcarbamate derivative of galantamine acts as an allosteric potentiating ligand on alpha7 nicotinic receptors in hippocampal neurons: clinical implications for treatment of Alzheimer's disease. J Mol Neurosci 30:227-232
-
(2006)
J Mol Neurosci
, vol.30
, pp. 227-232
-
-
Popa, R.V.1
Pereira, E.F.2
Lopes, C.3
Maelicke, A.4
Albuquerque, E.X.5
-
82
-
-
42149142899
-
Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: A randomized, double-blind, placebo-controlled trial
-
Memantine MEM-MD-12 Study Group 18288936 1:CAS:528:DC%2BD1cXitF2kurs%3D
-
Porsteinsson AP, Grossberg GT, Mintzer J, Olin JT, Memantine MEM-MD-12 Study Group (2008) Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial. Curr Alzheimer Res 5:83-89
-
(2008)
Curr Alzheimer Res
, vol.5
, pp. 83-89
-
-
Porsteinsson, A.P.1
Grossberg, G.T.2
Mintzer, J.3
Olin, J.T.4
-
83
-
-
0037417238
-
Memantine in moderate-to-severe Alzheimer's disease
-
Memantine Study Group 12672860 1:CAS:528:DC%2BD3sXis1egt7k%3D
-
Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Mobius HJ, Memantine Study Group (2003) Memantine in moderate-to-severe Alzheimer's disease. New Engl J Med 348:1333-1341
-
(2003)
New Engl J Med
, vol.348
, pp. 1333-1341
-
-
Reisberg, B.1
Doody, R.2
Stöffler, A.3
Schmitt, F.4
Ferris, S.5
Mobius, H.J.6
-
85
-
-
33845452780
-
Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: An exploratory reanalysis
-
for the Memantine MEM-MD-02 Study Group 17132970 1:CAS:528: DC%2BD28Xht1Cnt77M
-
Schmitt FA, van Dyck CH, Wichems CH, Olin JT, for the Memantine MEM-MD-02 Study Group (2006) Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis. Alzheimer Dis Assoc Disord 20:255-262
-
(2006)
Alzheimer Dis Assoc Disord
, vol.20
, pp. 255-262
-
-
Schmitt, F.A.1
Van Dyck, C.H.2
Wichems, C.H.3
Olin, J.T.4
-
86
-
-
43649099862
-
Steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer's disease not affected by co-administration of memantine: An open-label, crossover, single-centre study
-
18479178 1:CAS:528:DC%2BD1cXosFGks74%3D
-
Shua-Haim J, Smith J, Picard F, Sedek G, Athalye S, Pommier F, Lefevre G (2008) Steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer's disease not affected by co-administration of memantine: an open-label, crossover, single-centre study. Clin Drug Investig 28:361-374
-
(2008)
Clin Drug Investig
, vol.28
, pp. 361-374
-
-
Shua-Haim, J.1
Smith, J.2
Picard, F.3
Sedek, G.4
Athalye, S.5
Pommier, F.6
Lefevre, G.7
-
87
-
-
0020657372
-
Presynaptic cholinergic dysfunction in patients with dementia
-
6822833 1:STN:280:DyaL3s7htFShtg%3D%3D
-
Sims NR, Bowen DM, Allen SJ, Smith CC, Neary D, Thomas DJ, Davison AN (1983) Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem 40:503-509
-
(1983)
J Neurochem
, vol.40
, pp. 503-509
-
-
Sims, N.R.1
Bowen, D.M.2
Allen, S.J.3
Smith, C.C.4
Neary, D.5
Thomas, D.J.6
Davison, A.N.7
-
88
-
-
27744527103
-
Divergent effects of Abeta1-42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo
-
16248989 1:CAS:528:DC%2BD2MXht1ensr%2FK
-
Szegedi V, Juhász G, Budai D, Penke B (2005) Divergent effects of Abeta1-42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo. Brain Res 1062:120-126
-
(2005)
Brain Res
, vol.1062
, pp. 120-126
-
-
Szegedi, V.1
Juhász, G.2
Budai, D.3
Penke, B.4
-
89
-
-
78650057569
-
Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors
-
20947502 1:CAS:528:DC%2BC3cXhsFChtL3E
-
Takata K, Kitamura Y, Saeki M et al (2010) Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors. J Biol Chem 285:40180-40191
-
(2010)
J Biol Chem
, vol.285
, pp. 40180-40191
-
-
Takata, K.1
Kitamura, Y.2
Saeki, M.3
-
90
-
-
0345872128
-
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. A randomized controlled trial
-
Memantine Study Group 14734594 1:CAS:528:DC%2BD2cXmtlantA%3D%3D
-
Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I, Memantine Study Group (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. A randomized controlled trial. JAMA 291:317-324
-
(2004)
JAMA
, vol.291
, pp. 317-324
-
-
Tariot, P.N.1
Farlow, M.R.2
Grossberg, G.T.3
Graham, S.M.4
McDonald, S.5
Gergel, I.6
-
91
-
-
0042433479
-
The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development
-
12805474 1:CAS:528:DC%2BD3sXmvVehsb8%3D
-
Terry AV Jr, Buccafusco JJ (2003) The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306:821-827
-
(2003)
J Pharmacol Exp Ther
, vol.306
, pp. 821-827
-
-
Terry, Jr.A.V.1
Buccafusco, J.J.2
-
92
-
-
77952351441
-
G protein-coupled receptors, cholinergic dysfunction, and Abeta toxicity in Alzheimer's disease
-
Thathiah A, De Strooper B (2009) G protein-coupled receptors, cholinergic dysfunction, and Abeta toxicity in Alzheimer's disease. Sci Signal 2:1-7
-
(2009)
Sci Signal
, vol.2
, pp. 1-7
-
-
Thathiah, A.1
De Strooper, B.2
-
93
-
-
0035958739
-
Cholinergic nerve terminals establish classical synapses in the rat cerebral cortex: Synaptic pattern and age-related atrophy
-
11672595 1:CAS:528:DC%2BD3MXlslersbk%3D
-
Turrini P, Casu MA, Wong TP, De Koninck Y, Ribeiro-da-Silva A, Cuello AC (2001) Cholinergic nerve terminals establish classical synapses in the rat cerebral cortex: synaptic pattern and age-related atrophy. Neuroscience 105:277-285
-
(2001)
Neuroscience
, vol.105
, pp. 277-285
-
-
Turrini, P.1
Casu, M.A.2
Wong, T.P.3
De Koninck, Y.4
Ribeiro-Da-Silva, A.5
Cuello, A.C.6
-
94
-
-
33646459451
-
A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil
-
Memantine MEM-MD-02 Study Group 16670247
-
van Dyck CH, Schmitt FA, Olin JT, Memantine MEM-MD-02 Study Group (2006) A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil. Am J Geriatr Psychiatry 14:428-437
-
(2006)
Am J Geriatr Psychiatry
, vol.14
, pp. 428-437
-
-
Van Dyck, C.H.1
Schmitt, F.A.2
Olin, J.T.3
-
95
-
-
46249099143
-
Memantine therapy for Alzheimer disease in real-world practice: An observational study in a large representative sample of French patients
-
18525283 1:CAS:528:DC%2BD1cXms1ymtrk%3D
-
Vidal JS, Lacombe JM, Dartigues JF, Pasquier F, Robert P, Tzourio C, Alperovitch A (2008) Memantine therapy for Alzheimer disease in real-world practice: an observational study in a large representative sample of French patients. Alzheimer Dis Assoc Disord 22:125-130
-
(2008)
Alzheimer Dis Assoc Disord
, vol.22
, pp. 125-130
-
-
Vidal, J.S.1
Lacombe, J.M.2
Dartigues, J.F.3
Pasquier, F.4
Robert, P.5
Tzourio, C.6
Alperovitch, A.7
-
97
-
-
0032741056
-
Selectivity of cholinesterase inhibition: Clinical implications for the treatment of Alzheimer's disease
-
1:CAS:528:DyaK1MXnsVehtLk%3D
-
Weinstock M (1999) Selectivity of cholinesterase inhibition: clinical implications for the treatment of Alzheimer's disease. CNS Drugs 12:307-323
-
(1999)
CNS Drugs
, vol.12
, pp. 307-323
-
-
Weinstock, M.1
-
98
-
-
0028048433
-
Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat
-
7812791 1:CAS:528:DyaK2cXlslWisbw%3D
-
Wenk GL, Danysz W, Mobley SL (1994) Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat. Brain Res 655:7-11
-
(1994)
Brain Res
, vol.655
, pp. 7-11
-
-
Wenk, G.L.1
Danysz, W.2
Mobley, S.L.3
-
99
-
-
0028980903
-
MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis
-
8666045 1:CAS:528:DyaK2MXosVOisLc%3D
-
Wenk GL, Danysz W, Mobley SL (1995) MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis. Eur J Pharmacol 293:267-270
-
(1995)
Eur J Pharmacol
, vol.293
, pp. 267-270
-
-
Wenk, G.L.1
Danysz, W.2
Mobley, S.L.3
-
100
-
-
0034635589
-
No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use
-
10737358 1:CAS:528:DC%2BD3cXhsVKisL0%3D
-
Wenk GL, Quack G, Moebius HJ, Danysz W (2000) No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use. Life Sci 66:1079-1083
-
(2000)
Life Sci
, vol.66
, pp. 1079-1083
-
-
Wenk, G.L.1
Quack, G.2
Moebius, H.J.3
Danysz, W.4
-
101
-
-
33748296153
-
Potential role of N-methyl-d-aspartate receptors as executors of neurodegeneration resulting from diverse insults: Focus on memantine
-
16940762 1:CAS:528:DC%2BD28XoslOnt74%3D
-
Wenk GL, Parsons CG, Danysz W (2006) Potential role of N-methyl-d-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine. Behav Pharmacol 17:411-424
-
(2006)
Behav Pharmacol
, vol.17
, pp. 411-424
-
-
Wenk, G.L.1
Parsons, C.G.2
Danysz, W.3
-
102
-
-
34249037440
-
Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil
-
17519086 1:CAS:528:DC%2BD2sXnt1Whu7w%3D
-
Weycker D, Taneja C, Edelsberg J, Erder MH, Schmitt FA, Setyawan J, Oster G (2007) Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil. Curr Med Res Opin 23:1187-1197
-
(2007)
Curr Med Res Opin
, vol.23
, pp. 1187-1197
-
-
Weycker, D.1
Taneja, C.2
Edelsberg, J.3
Erder, M.H.4
Schmitt, F.A.5
Setyawan, J.6
Oster, G.7
-
103
-
-
42249111378
-
Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: A pooled analysis of 3 studies
-
18294023 1:CAS:528:DC%2BD1cXltVKhur0%3D
-
Wilcock GK, Ballard CG, Cooper JA, Loft H (2008) Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. J Clin Psychiatry 69:341-348
-
(2008)
J Clin Psychiatry
, vol.69
, pp. 341-348
-
-
Wilcock, G.K.1
Ballard, C.G.2
Cooper, J.A.3
Loft, H.4
-
104
-
-
34447633346
-
Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease
-
17622761 1:CAS:528:DC%2BD2sXotVajs7c%3D
-
Wilkinson D, Andersen HF (2007) Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease. Dement Geriatr Cogn Disord 24:138-145
-
(2007)
Dement Geriatr Cogn Disord
, vol.24
, pp. 138-145
-
-
Wilkinson, D.1
Andersen, H.F.2
-
105
-
-
2942514710
-
Cholinesterase inhibitors used in the treatment of Alzheimer's disease: The relationship between pharmacological effects and clinical efficacy
-
15132713 1:CAS:528:DC%2BD2cXlsVCmurg%3D
-
Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J (2004) Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging 21:453-478
-
(2004)
Drugs Aging
, vol.21
, pp. 453-478
-
-
Wilkinson, D.G.1
Francis, P.T.2
Schwam, E.3
Payne-Parrish, J.4
-
106
-
-
0033856448
-
The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclo-oxygenase-2 inhibition
-
11026726 1:CAS:528:DC%2BD3cXnsVers7o%3D
-
Willard LB, Hauss-Wegrzyniak B, Danysz W, Wenk GL (2000) The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclo-oxygenase-2 inhibition. Exp Brain Res 134:58-65
-
(2000)
Exp Brain Res
, vol.134
, pp. 58-65
-
-
Willard, L.B.1
Hauss-Wegrzyniak, B.2
Danysz, W.3
Wenk, G.L.4
-
107
-
-
34250797930
-
Memantine in moderate to severe Alzheimer's disease: A meta-analysis of randomised clinical trials
-
17496417 1:CAS:528:DC%2BD2sXmvFSnu7c%3D
-
Winblad B, Jones RW, Wirth Y, Stöffler A, Möbius HJ (2007) Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials. Dement Geriatr Cogn Disord 24:20-27
-
(2007)
Dement Geriatr Cogn Disord
, vol.24
, pp. 20-27
-
-
Winblad, B.1
Jones, R.W.2
Wirth, Y.3
Stöffler, A.4
Möbius, H.J.5
-
108
-
-
0029417021
-
β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus
-
8747164 1:CAS:528:DyaK28XhtVOjurk%3D
-
Wu J, Anwyl R, Rowan MJ (1995) β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. NeuroReport 6:2409-2413
-
(1995)
NeuroReport
, vol.6
, pp. 2409-2413
-
-
Wu, J.1
Anwyl, R.2
Rowan, M.J.3
-
109
-
-
3142666106
-
Group i metabotropic glutamate receptor activation produces a direct excitation of identified septohippocampal cholinergic neurons
-
15044519 1:CAS:528:DC%2BD2cXmslCnt7s%3D
-
Wu M, Hajszan T, Xu C, Leranth C, Alreja M (2004) Group I metabotropic glutamate receptor activation produces a direct excitation of identified septohippocampal cholinergic neurons. J Neurophysiol 92:1216-1225
-
(2004)
J Neurophysiol
, vol.92
, pp. 1216-1225
-
-
Wu, M.1
Hajszan, T.2
Xu, C.3
Leranth, C.4
Alreja, M.5
-
110
-
-
17644406408
-
Steady-state pharmacokinetics of galantamine are not affected by addition of memantine in healthy subjects
-
15831775 1:CAS:528:DC%2BD2MXkvVWmtrw%3D
-
Yao C, Raoufinia A, Gold M, Nye JS, Ramael S, Padmanabhan M, Walschap Y, Verhaeghe T, Zhao Q (2005) Steady-state pharmacokinetics of galantamine are not affected by addition of memantine in healthy subjects. J Clin Pharmacol 45:519-528
-
(2005)
J Clin Pharmacol
, vol.45
, pp. 519-528
-
-
Yao, C.1
Raoufinia, A.2
Gold, M.3
Nye, J.S.4
Ramael, S.5
Padmanabhan, M.6
Walschap, Y.7
Verhaeghe, T.8
Zhao, Q.9
-
111
-
-
0030841116
-
Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP
-
9257940 1:CAS:528:DyaK2sXkvFCltrs%3D
-
Zajaczkowski W, Frankiewicz T, Parsons CG, Danysz W (1997) Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP. Neuropharmacology 36:961-971
-
(1997)
Neuropharmacology
, vol.36
, pp. 961-971
-
-
Zajaczkowski, W.1
Frankiewicz, T.2
Parsons, C.G.3
Danysz, W.4
|